Skip to content

Artiva Biotherapeutics, Inc. ARTV Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

Gilead Sciences logo
Gilead SciencesGILD
Allogene Therapeutics logo
Allogene TherapeuticsALLO
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Market cap$429.03M+1,015%
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s property, plant and equipment at cost?
Artiva Biotherapeutics, Inc. (ARTV) reported property, plant and equipment at cost of $15.32M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s property, plant and equipment at cost changed year-over-year?
Artiva Biotherapeutics, Inc.'s property, plant and equipment at cost increased by 12.7% year-over-year, from $13.59M to $15.32M.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s property, plant and equipment at cost?
Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s property, plant and equipment at cost has grown at a 13.9% compound annual growth rate (CAGR), from $11.63M to $15.08M.